CompletedNCT05451589
Official study titleImproving Physical and Psychosocial Functioning in Older Adults: A Community Health Worker-Led Intervention
This study has finished and is no longer accepting participants.
In Ann ArborDepression, AnxietyBehavioural studyAges 50+
- Countries
- United States
- Sponsor
- University of Michigan
CompletedACTRN12619001671156
Official study titleThe LifeBuoy App: A randomised controlled trial of a mHealth intervention to help young people manage suicidal thoughts
This study has finished and is no longer accepting participants.
In AustraliaSuicidalityInterventional studyAges 16–25
- Countries
- Australia
- Sponsor
- University of New South Wales
CompletedNCT04100096
Official study titleA Multicenter, Randomized, Flexible-dose, Double-blind Trial of Brexpiprazole Versus Placebo for the Treatment of Adults With Borderline Personality Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvillePersonality disordersMedication studyAges 18–65
- Countries
- United States, Spain, Ukraine
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT05257265
What is this study about?Researchers compared Centanafadine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in young people with ADHD.
This study has finished and is no longer accepting participants.
In New YorkADHDMedication studyAges 13–17
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT05428033
What is this study about?This study evaluated the safety and effectiveness of centanafadine capsule for people with ADHD.
This study has finished and is no longer accepting participants.
In New YorkADHDMedication studyAges 4–12
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT05113953
Official study titleA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets After Oral Administration in Adult Subjects With Binge Eating Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixEating disordersMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT05279313
What is this study about?Researchers studied Centanafadine Hydrochloride, tracking side effects to assess long-term safety and tolerability in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanADHDMedication studyAges 4–18
- Countries
- United States, Canada
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedACTRN12609000348257
Official study titleA trial of Cognitive Behavioural Therapy with adult clients diagnosed with Asperger's Disorder, to treat anxiety and depression
This study has finished and is no longer accepting participants.
Location not clearly listedAnxiety, DepressionInterventional studyAges 18+
- Countries
- Sponsor
- University of South Australia
WithdrawnNCT02476331
Official study titleA Randomized Control Trial of Cognitive Training in Euthymic Bipolar Disorder
This study was withdrawn before enrollment.
In CalgaryBipolarityBehavioural studyAges 18–65
- Countries
- Canada
- Sponsor
- University of Calgary
CompletedNCT02478827
Official study titleA Trial of Cognitive Training in Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including CalgarySchizophreniaBehavioural studyAges 18–65
- Countries
- Canada
- Sponsor
- University of Calgary
CompletedNCT06706739
What is this study about?This study assessed thinking abilities.
This study has finished and is no longer accepting participants.
In FuzhouDepressionInterventional studyAges 60+
- Countries
- China
- Sponsor
- Fujian Medical University
CompletedNCT00956605
About this title
A Trial of Computer-based Attention-training Systems in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Read the official source — NCT00956605Official study titleA Randomized Trial of Computer-based Attention-training Systems With and Without Neurofeedback in Children With ADHD
This study has finished and is no longer accepting participants.
In BostonADHDBehavioural studyAges 10–15
- Countries
- United States
- Sponsor
- Tufts Medical Center